Cedar Brook Financial Partners, LLC Biogen Inc. Transaction History

Cedar Brook Financial Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 01, 2021	SELL	$282.99 - $369.05 $165,549 - $215,894	-585 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $151,515 - $242,605	585 New	585 $203,000
Q1 2019 May 08, 2019	SELL	$216.71 - $338.96 $152,780 - $238,966	-705 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$278.5 - $352.75 $196,342 - $248,688	705 New	705 $212,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Cedar Brook Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cedar Brook Financial Partners, LLC with notifications on news.